Unimolecular polymeric micelles with an ionizable inner core

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S468000, C514S002600, C514S04400A

Reexamination Certificate

active

06780428

ABSTRACT:

FIELD OF THE INVENTION
This invention relates generally to the field of unimolecular polymeric micelles (UPM); particularly to UPM and their methods of preparation which result in a micelle having an ionizable core; and most particularly to the use of such micelles as carriers for pharmacological constituents; wherein a directed release of said constituents in response to the ionization state induced upon the UPM is realized.
BACKGROUND OF THE INVENTION
In order to improve the specific delivery of drugs with a low therapeutic index, several drug carriers such as liposomes, microparticles, nano-associates (e.g. polymeric micelles, polyion complex micelles (PICM)) and drug-polymer conjugates have been studied. In recent years, water-soluble supramolecular assemblies such as polymeric micelles and PICM have emerged as promising new colloidal carriers for the delivery of hydrophobic drugs and polyions (e.g. antisense oligonucleotides), respectively.
Polymeric micelles have been the object of growing scientific attention, and have emerged as potential carriers for drugs having poor water solubility because they can solubilize those drugs in their inner core and they offer attractive characteristics such as a generally small size (<300 nm) and a propensity to evade scavenging by the mononuclear phagocyte system.
Micelles are often compared to naturally occurring carriers such as viruses or lipoproteins. All three of these carriers demonstrate a similar core-shell structure that allows for their contents to be protected during transportation to the target cell, whether it is DNA for viruses or water-insoluble drugs for lipoproteins and micelles.
Polymeric micelles seem to be one of the most advantageous carriers for the delivery of poorly water-soluble drugs as reported by Jones and Leroux,
Eur. J. Pharm. Biopharm
. (1999) 48, 101-111; Kwon and Okano,
Adv. Drug Deliv. Rev
. (1996) 21, 107-116 and Allen et al.
Colloids Surf. B: Biointerf
. (1999) 16, 3-27. They are characterized by a core-shell structure. The hydrophobic inner core generally serves as a microenvironment for the solubilization of poorly water-soluble drugs, whereas the hydrophilic outer shell is responsible for micelle stability, protection against opsonization, and uptake by the mononuclear phagocyte system. Pharmaceutical research on polymeric micelles has been mainly focused on copolymers having an AB diblock structure with A, the hydrophilic shell moieties and B the hydrophobic core polymers, respectively. Multiblock copolymers such as poly(ethylene oxide)-poly(propyleneoxide)-poly(ethylene oxide) (PEO-PPO-PEO) (A-B-A) can also self-organize into micelles, and have been described as potential drug carriers. E.g. Kabanov et al.,
FEBBS Lett
. (1989) 258, 343-345. The hydrophobic core which generally consists of a biodegradable polymer such as a poly(&bgr;-benzyl-aspartate) (PBLA), poly(D,L-lactic acid) or poly(&egr;-caprolactone), serves as a reservoir for a poorly water-soluble drug, protecting it from contact with the aqueous environment. The core may also consist of a water-soluble polymer, such as poly(aspartic acid) (P(Asp)), which is rendered hydrophobic by the chemical conjugation of a hydrophobic drug, or is formed through the association of two oppositely charged polyions (PICM). Several studies also describe the use of poorly or non-biodegradable polymers, such as polystyrene (PSt) or poly(methyl methacrylate)(PMMA), as constituents of the inner core. See, e.g., Zhao et al.,
Langmuir
(1990) 6, 514-516; Zhang et al.,
Science
(1995) 268, 1728-1731; Inoue et al.,
J. Controlled Release
(1998) 51, 221-229 and Kataoka
J. Macromol. Sci. Pure Appl. Chem
. (1994) A31, 1759-1769. The hydrophobic inner core can also consist of a highly hydrophobic small chain such as an alkyl chain or a diacyllipid (e.g. distearoyl phosphatidyl ethanolamine). The hydrophobic chain can be either attached to one end of a polymer, or randomly distributed within the polymeric structure. The shell usually consists of chains of hydrophilic, non-biodegradable, biocompatible polymers such as poly(ethylene oxide) (PEO) (see Allen et al.
Colloids Surf. B: Biointerf
. (1999) 16, 3-27 and Kataoka et al.
J. Controlled Release
(2000) 64, 143-153), poly(N-vinyl-2-pyrrolidone) (PVP) (see Benahmed A et al.
Pharm Res
(2001) 18, 323-328) or poly(2ethyl-2-oxazoline) (see Lee et al.
Macromolecules
(1999) 32, 1847-1852). The biodistribution of the carrier is mainly dictated by the nature of the hydrophilic shell. Other polymers such as poly(N-isopropylacrylamide) and poly(alkylacrylic acid) impart temperature or pH sensitivity to the micelles, and could eventually be used to confer bioadhesive properties (see U.S. Pat. No. 5,770,627). Micelles presenting functional groups at their surface for conjugation with a targeting moiety have also been described (See, e.g., Scholz, C. et al.,
Macromolecules
(1995) 28, 7295-7297).
Unimolecular polymeric micelles (UPM) consist of a single macromolecule having an inner core and an outer shell which differ in their hydrophobic and hydrophilic character (see Liu et al.
J. Polym. Sci. Part A: Polym. Chem
. (1999) 37, 703-711; Liu et al.
J. Controlled Release
(2000) 65, 121-131). In drug delivery, unimolecular polymeric micelles possess generally a hydrophobic core and a hydrophilic corona. As opposed to supramolecular assemblies, unimolecular micelles are intrinsically stable because they do not show any critical association concentration (CAC per se). Such micelles can solubilize poorly water-soluble compounds and be used as carriers for drug targeting. Since unimolecular micelles do not dissociate upon dilution, compounds are usually released from the inner core by diffusion and/or following the degradation of the polymer backbone (see Liu et al.
J. Controlled Release
(2000) 68, 167-171). In the case of non biodegradable unimolecular micelles, diffusion is the sole mechanism of drug release.
What is therefore lacking in the prior art is a UPM which is designed to have a more elegant means for release of their contents. More specifically, if a UPM was synthesized with an ionizable inner core, it could be useful in a variety of pharmaceutical applications. For instance, micelles intended to be administered by the oral route can be designed to have a core bearing carboxylic acid groups. Hydrophobic or substantially hydrophobic drugs will be loaded in the inner core under conditions where the latter is protonated. Such micelles should release their contents in the small intestine as the pH rises.
DESCRIPTION OF THE PRIOR ART
U.S. Pat. No. 5,714,166 discloses dendritic polymer conjugates which are composed of at least one dendrimer in association with at least one unit of a carried material, where the carrier material can be a biological response modifier, have been prepared. The conjugate can also have a target director present, and when it is present then the carried material may be a bioactive agent. Preferred dendritic polymers are dense star polymers, which have been complexed with biological response modifiers. These conjugates and complexes have particularly advantageous properties due to their unique characteristics.
U.S. Pat. No. 6,177,414 is directed toward starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer. The carried material is salicylic acid and the dendrimer polymer is a polyamidoamine.
U.S. Pat. No. 6,130,209 relates a key micelle molecule comprising a core molecule and a plurality of branches extending thereform, at least one of said branches including a shank portion extending thereform having a terminal moiety at an end thereof providing a secondary and tertiary structure allowing entrance into a void region of a lock micelle for binding to a complementary acceptor within the void region of the lock unimolecular micelle.
U.S. Pat. No. 5,154,853 cites a met

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Unimolecular polymeric micelles with an ionizable inner core does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Unimolecular polymeric micelles with an ionizable inner core, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Unimolecular polymeric micelles with an ionizable inner core will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3271751

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.